CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.

Perdagangan Astria Therapeutics, Inc. - ATXS CFD

-
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread -
Biaya inap posisi Long

Long position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight -0.024874 %
Charges from borrowed part ($-0.99)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
-0.024874%
Biaya inap posisi short

Short position overnight fee


Margin. Your investment $1,000.00
Biaya Overnight 0.002651 %
Charges from borrowed part ($0.11)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Kunjungi platform
0.002651%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 2.36-16.28
Average Volume (10 days) 239.64K
Average Volume (3 months) 4.84M
Market Cap 372.22M
P/E Ratio -100.00K
Shares Outstanding 27.99M
Revenue N/A
EPS -3.62
Dividend (Yield %) N/A
Beta 0.91
Next Earnings Date May 10, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low

Astria Therapeutics, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 0 0 0 0 0
Total Operating Expense 53.503 194.976 37.435 27.088 26.371
Selling/General/Admin. Expenses, Total 19.239 14.807 11.845 8.771 9.329
Research & Development 34.264 180.169 25.59 18.317 17.042
Operating Income -53.503 -194.976 -37.435 -27.088 -26.371
Interest Income (Expense), Net Non-Operating 1.724 0.122 0.236 0.845 0.325
Other, Net -0.055 -0.058 -0.101 -0.05 0.176
Net Income Before Taxes -51.834 -194.912 -37.3 -26.293 -25.87
Net Income After Taxes -51.834 -194.912 -37.3 -26.293 -25.87
Net Income Before Extra. Items -51.834 -194.912 -37.3 -26.293 -25.87
Net Income -51.834 -194.912 -37.3 -26.293 -25.87
Income Available to Common Excl. Extra. Items -51.834 -219.349 -37.3 -26.293 -25.87
Income Available to Common Incl. Extra. Items -51.834 -219.349 -37.3 -26.293 -25.87
Diluted Net Income -51.834 -219.349 -37.3 -26.293 -25.87
Diluted Weighted Average Shares 14.6206 8.92517 3.05864 1.86655 0.84249
Diluted EPS Excluding Extraordinary Items -3.54527 -24.5764 -12.195 -14.0864 -30.7067
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -3.54527 -24.5764 -12.195 -14.0864 -30.7067
Revenue 0
Total Extraordinary Items
Total Adjustments to Net Income 0 -24.437
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Total revenue 0 0 0 0 0
Total Operating Expense 14.29 12.386 11.449 15.378 9.508
Selling/General/Admin. Expenses, Total 4.699 4.688 4.832 5.02 3.815
Research & Development 9.591 7.698 6.617 10.358 5.693
Operating Income -14.29 -12.386 -11.449 -15.378 -9.508
Other, Net 0.009 -0.048 -0.015 -0.001 -0.016
Net Income Before Taxes -13.263 -11.997 -11.25 -15.323 -9.491
Net Income After Taxes -13.263 -11.997 -11.25 -15.323 -9.491
Net Income Before Extra. Items -13.263 -11.997 -11.25 -15.323 -9.491
Net Income -13.263 -11.997 -11.25 -15.323 -9.491
Income Available to Common Excl. Extra. Items -13.263 -11.997 -11.25 -15.323 -9.491
Income Available to Common Incl. Extra. Items -13.263 -11.997 -11.25 -15.323 -9.491
Diluted Net Income -13.263 -11.997 -11.25 -15.323 -9.491
Diluted Weighted Average Shares 18.6982 13.7424 13.017 13.017 13.0598
Diluted EPS Excluding Extraordinary Items -0.70932 -0.87299 -0.86426 -1.17716 -0.72673
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.70932 -0.87299 -0.86426 -1.17716 -0.72673
Interest Income (Expense), Net Non-Operating 1.018 0.437 0.214 0.056 0.033
Total Adjustments to Net Income 0 0 0 0
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 127.075 46.325 38.958 38.915 17.463
Cash and Short Term Investments 125.508 44.93 36.244 37.57 16.369
Cash & Equivalents 1.853 22.999 5.432 5.956 16.369
Short Term Investments 39 20 26.345 22.276 0
Prepaid Expenses 1.446 1.274 2.237 1.345 1.094
Total Assets 127.514 47.456 41.78 39.169 17.897
Property/Plant/Equipment, Total - Net 0.394 0.966 2.349 0.056 0.321
Property/Plant/Equipment, Total - Gross 0.377
Accumulated Depreciation, Total -0.321
Other Long Term Assets, Total 0.045 0.165 0.473 0.198 0.113
Total Current Liabilities 5.203 6.39 5.032 4.171 6.016
Accounts Payable 1.557 1.544 1.197 1.408 0.773
Accrued Expenses 3.646 4.846 3.835 2.763 2.432
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 2.479
Total Liabilities 5.203 6.787 6.06 4.227 6.105
Total Long Term Debt 0 0 0 0 0
Long Term Debt 0
Other Liabilities, Total 0 0.397 1.028 0.056 0.089
Total Equity 122.311 40.669 35.72 34.942 11.792
Common Stock 0.013 0.02 0.012 0.007 0.024
Additional Paid-In Capital 481.709 301.546 259.305 232.243 183.202
Retained Earnings (Accumulated Deficit) -455.809 -260.897 -223.597 -197.304 -171.434
Other Equity, Total 0 0 -0.004 0
Total Liabilities & Shareholders’ Equity 127.514 47.456 41.78 39.169 17.897
Total Common Shares Outstanding 13.017 3.34746 2.07227 0.11903 0.3941
Other Current Liabilities, Total 0 0.332
Preferred Stock - Non Redeemable, Net 96.398 0 0 0
Cash 84.655 1.931 4.467 9.338
Other Current Assets, Total 0.121 0.121 0.477
Total Preferred Shares Outstanding 0.03146
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 114.221 127.075 134.522 140.052 147.684
Cash and Short Term Investments 112.816 125.508 131.777 139.52 146.92
Cash & Equivalents 46.687 86.508 131.777 139.52 146.92
Short Term Investments 66.129 39 0 0 0
Prepaid Expenses 1.121 1.446 2.624 0.411 0.643
Other Current Assets, Total 0.284 0.121 0.121 0.121 0.121
Total Assets 114.653 127.514 135.129 140.945 148.74
Property/Plant/Equipment, Total - Net 0.228 0.394 0.557 0.717 0.874
Other Long Term Assets, Total 0.204 0.045 0.05 0.176 0.182
Total Current Liabilities 4.967 5.203 4.7 3.988 4.406
Accounts Payable 0.931 1.557 0.574 0.619 1.809
Accrued Expenses 4.036 3.646 4.126 3.369 2.597
Notes Payable/Short Term Debt 0 0 0 0 0
Total Liabilities 4.967 5.203 4.7 4.046 9.004
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0 0 0.058 4.598
Total Equity 109.686 122.311 130.429 136.899 139.736
Preferred Stock - Non Redeemable, Net 96.398 96.398 96.398 99.77 240.881
Common Stock 0.013 0.013 0.013 0.077 0.023
Additional Paid-In Capital 484.46 481.709 480.336 475.499 329.813
Retained Earnings (Accumulated Deficit) -471.132 -455.809 -446.318 -438.447 -430.981
Total Liabilities & Shareholders’ Equity 114.653 127.514 135.129 140.945 148.74
Total Common Shares Outstanding 13.017 13.017 13.0095 12.8248 3.90283
Total Preferred Shares Outstanding 0.03146 0.03146 0.03146 0.03255
Other Equity, Total -0.053 0
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -51.834 -194.912 -37.3 -26.293 -25.87
Cash From Operating Activities -43.533 -30.151 -32.485 -26.569 -23.465
Cash From Operating Activities 0.026 0.119
Non-Cash Items 5.654 168.066 1.448 1.568 1.524
Cash Interest Paid 0 0.079
Changes in Working Capital 2.647 -3.305 3.367 -1.87 0.762
Cash From Investing Activities -167.129 -12.555 6.3 -4.082 -21.905
Capital Expenditures -0.091 -0.021 -0.033 -0.012 0
Other Investing Cash Flow Items, Total -167.038 -12.534 6.333 -4.07 -21.905
Cash From Financing Activities 144.721 104.284 40.86 25.62 44.295
Issuance (Retirement) of Stock, Net 144.721 104.284 40.86 25.62 47.143
Issuance (Retirement) of Debt, Net 0 -2.848
Net Change in Cash -65.941 61.578 14.675 -5.031 -1.075
Financing Cash Flow Items
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Net income/Starting Line -51.834 -38.571 -26.574 -15.323 -194.912
Cash From Operating Activities -43.533 -32.869 -22.62 -12.559 -30.151
Non-Cash Items 5.654 5.15 3.947 2.672 168.066
Changes in Working Capital 2.647 0.552 0.007 0.092 -3.305
Cash From Investing Activities -167.129 -31.949 -33.899 -27.099 -12.555
Capital Expenditures -0.091 -0.06 -0.002 0 -0.021
Other Investing Cash Flow Items, Total -167.038 -31.889 -33.897 -27.099 -12.534
Cash From Financing Activities 144.721 24.324 0 0 104.284
Issuance (Retirement) of Stock, Net 144.721 24.324 0 0 104.284
Net Change in Cash -65.941 -40.494 -56.519 -39.658 61.578
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Fidelity Management & Research Company LLC Investment Advisor 11.9754 3351514 2974069 2022-12-31 LOW
Perceptive Advisors LLC Private Equity 7.8232 2189462 908265 2022-12-31 MED
Fairmount Funds Management LLC Hedge Fund 6.7939 1901397 989661 2022-12-31 HIGH
Deep Track Capital LP Hedge Fund 6.4907 1816531 1816531 2022-12-31 MED
Vivo Capital, LLC Venture Capital 6.0071 1681199 681199 2022-12-31 MED
Cormorant Asset Management, LP Hedge Fund 5.8957 1650000 450000 2022-12-31 MED
Altium Capital Management LP Investment Advisor/Hedge Fund 4.8429 1355372 910372 2022-12-31 HIGH
Driehaus Capital Management, LLC Investment Advisor/Hedge Fund 4.7784 1337315 680954 2022-12-31 MED
Logos Global Management LLC Investment Advisor 3.0906 864960 864960 2022-12-31 HIGH
Ikarian Capital LLC Hedge Fund 2.4125 675176 -24264 2022-12-31 HIGH
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.338 654326 123173 2022-12-31 LOW
Rosalind Advisors, Inc. Hedge Fund 2.3348 653438 653438 2021-12-31 LOW
Tri Locum Partners LP Hedge Fund 2.3273 651330 19751 2022-12-31 HIGH
Affinity Asset Advisors LLC Hedge Fund 1.6882 472482 72439 2022-12-31 HIGH
Sphera Funds Management Ltd. Hedge Fund 1.677 469340 469340 2022-12-31 MED
Ghost Tree Capital, LLC Hedge Fund 1.6079 450000 -50000 2022-12-31 HIGH
Violin (Jonathan) Individual Investor 0.9409 263321 0 2022-04-13 LOW
Opaleye Management Inc. Hedge Fund 0.9351 261703 128203 2022-12-31 MED
Medical Strategy GmbH Investment Advisor 0.9026 252605 -18814 2022-09-30 LOW
Point72 Asset Management, L.P. Hedge Fund 0.804 225000 225000 2022-12-31 HIGH

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Industry: Bio Therapeutic Drugs

75 State Street
Suite 1400
BOSTON
MASSACHUSETTS 02109
US

Income Statement

  • Annual
  • Quarterly

People also watch

BTC/USD

28,392.85 Price
-0.260% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Natural Gas

2.20 Price
+3.540% 1D Chg, %
Biaya inap posisi Long -0.4092%
Biaya inap posisi short 0.3873%
Waktu biaya inap 21:00 (UTC)
Spread 0.005

Oil - Crude

75.76 Price
+1.830% 1D Chg, %
Biaya inap posisi Long -0.0156%
Biaya inap posisi short -0.0063%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

Gold

1,969.66 Price
-0.550% 1D Chg, %
Biaya inap posisi Long -0.0185%
Biaya inap posisi short 0.0102%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda